Trade Biogen Inc. - BIIB CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.46 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.45 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 227.21 |
| Open | 215.1 |
| 1-Year Change | -20.39% |
| Day's Range | 210.92 - 216.62 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 227.33 | 1.35 | 0.60% | 225.98 | 236.09 | 224.95 |
| Jul 24, 2024 | 225.56 | 2.13 | 0.95% | 223.43 | 227.82 | 221.22 |
| Jul 23, 2024 | 224.07 | -0.31 | -0.14% | 224.38 | 227.77 | 223.13 |
| Jul 22, 2024 | 226.46 | 0.58 | 0.26% | 225.88 | 228.00 | 223.35 |
| Jul 19, 2024 | 225.40 | -0.12 | -0.05% | 225.52 | 226.98 | 221.88 |
| Jul 18, 2024 | 225.08 | 2.37 | 1.06% | 222.71 | 230.86 | 222.36 |
| Jul 17, 2024 | 227.46 | 5.49 | 2.47% | 221.97 | 229.96 | 220.84 |
| Jul 16, 2024 | 224.82 | 3.92 | 1.77% | 220.90 | 228.24 | 219.99 |
| Jul 15, 2024 | 221.22 | -7.68 | -3.36% | 228.90 | 229.20 | 220.67 |
| Jul 12, 2024 | 229.91 | -6.57 | -2.78% | 236.48 | 237.78 | 226.34 |
| Jul 11, 2024 | 236.52 | 3.03 | 1.30% | 233.49 | 237.83 | 230.87 |
| Jul 10, 2024 | 231.80 | 1.77 | 0.77% | 230.03 | 232.65 | 227.11 |
| Jul 9, 2024 | 228.91 | 1.79 | 0.79% | 227.12 | 229.21 | 225.16 |
| Jul 8, 2024 | 227.91 | 2.53 | 1.12% | 225.38 | 229.09 | 225.24 |
| Jul 5, 2024 | 225.44 | 1.74 | 0.78% | 223.70 | 226.16 | 222.97 |
| Jul 3, 2024 | 223.76 | -4.12 | -1.81% | 227.88 | 228.29 | 222.06 |
| Jul 2, 2024 | 228.58 | -2.66 | -1.15% | 231.24 | 232.87 | 224.96 |
| Jul 1, 2024 | 231.60 | 0.98 | 0.42% | 230.62 | 236.39 | 230.18 |
| Jun 28, 2024 | 230.65 | 1.94 | 0.85% | 228.71 | 235.11 | 226.82 |
| Jun 27, 2024 | 228.56 | 4.78 | 2.14% | 223.78 | 230.05 | 221.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Biogen Company profile
Biogen Inc. (BIIB) is a biotechnology company in the field of neurological and neurodegenerative diseases.
Established in 1978 and headquartered in Cambridge, Massachusetts, Biogen has devoted its scientific research to defeating neurological diseases, like multiple sclerosis, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
With the aid of some of the world’s leading neuroscientists and neurologists, Biogen has sought treatments against common diseases such as spinal muscular atrophy (SMA) and progressive supranuclear palsy (PSP).
The use of advanced technologies and engineering skills has enabled Biogen to bring effective medicines to the market. The company’s products include SPINRAZA for the treatment of SMA; TECFIDERA, AVONEX, FAMPYRA, VUMERITY and TYSABRI for multiple sclerosis; ADUHELM for Alzheimer’s disease; and FUMADERM for the treatment of severe plaque psoriasis.
Biogen has made an agreement with Genentech, a member of the Roche Group for business and financial rights, with respect to RITUXAN, GAZYVA and OCREVUS. It’s constantly looking at ways to improve its research and development to compete against other biotech giants like Pfizer Inc (PFE), Johnson & Johnson (JNJ) and Amgen (AMGN).
Biogen went public in September 1991. It trades on the Nasqaq under the ticker ‘BIIB’.
| Industry: | Biopharmaceuticals |
225 Binney Street
CAMBRIDGE
MASSACHUSETTS 02142
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com